Skip to main content
. 2014 Aug 21;2014(8):CD002913. doi: 10.1002/14651858.CD002913.pub3

Summary of findings 3. Budesonide 6 mg versus budesonide 3 mg for maintenance of remission in Crohn's disease.

Budesonide 6 mg versus budesonide 3 mg for maintenance of remission in Crohn's disease
Patient or population: patients with quiescent Crohn's disease
 Settings: outpatients
 Intervention: budesonide 6 mg versus budesonide 3 mg
Outcomes Illustrative comparative risks* (95% CI) Relative effect
 (95% CI) No of Participants
 (studies) Quality of the evidence
 (GRADE) Comments
Assumed risk Corresponding risk
Control Budesonide 6 mg versus budesonide 3 mg
Continued remission at 3 months 589 per 10001 630 per 1000
 (501 to 789) RR 1.07 
 (0.85 to 1.34) 180
 (3 studies) ⊕⊕⊕⊝
 Moderate2  
Continued remission at 6 months 489 per 10001 548 per 1000
 (416 to 719) RR 1.12 
 (0.85 to 1.47) 180
 (3 studies) ⊕⊕⊕⊝
 Moderate3  
Continued remission at 12 months 389 per 10001 459 per 1000
 (331 to 642) RR 1.18 
 (0.85 to 1.65) 180
 (3 studies) ⊕⊕⊕⊝
 Moderate4  
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
 CI: Confidence interval; RR: risk ratio
GRADE Working Group grades of evidence
 High quality: Further research is very unlikely to change our confidence in the estimate of effect.
 Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
 Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
 Very low quality: We are very uncertain about the estimate.

1 Control group risk estimates come from control arm of meta‐analysis, based on included trials.
 2 Sparse data (109 events).
 3 Sparse data (94 events).
 4 Sparse data (77 events).